Founded in 2021 and headquartered in St. Paul, Minnesota, Oncodea is dedicated to revolutionizing cancer detection through non-invasive and affordable technology. The company’s core mission is to make early-stage cancer detection accessible to everyone, leveraging AI and machine learning to enhance diagnostic accuracy. Oncodea’s primary product is a comprehensive cancer detection system designed for both individuals seeking preventive measures and patients monitoring their treatment progress.
Oncodea's team includes seasoned professionals with over 20 years of industry experience, contributing to its innovative approach and credibility. The company has garnered attention from notable investors in the healthcare technology sector, further solidifying its impact. Key achievements include the development of a user-friendly detection platform that has the potential to significantly reduce cancer mortality rates by enabling early diagnosis. Oncodea's technology promises to transform the landscape of cancer care, making it more accessible and effective for all.
